News

Compounding Pharmacies Market 2028 Size, Share, Trend and Forecast By US Compounding Inc, Fresenius Kabi AG, Fagron, Inc.

The compounding pharmacies market was valued at US$ 9,442.8 million in 2020 and is projected to reach US$ 14,995.1 million by 2028; it is expected to grow at a CAGR of 6.1% from 2021 to 2028.

The major factors driving to the growth of the market are the drug shortage crisis across the world, benefits associated with compounded medications, and increasing adoption of customized medicine (personalized medicine). However, product recalls and stringent regulatory requirements are restricting the Compounding Pharmacies market growth. Compounding pharmacy’s or compound pharmacy’s role is to mix ingredients as per patients’ needs and manufacture drugs that are not commercially available. Compounding pharmacies are essential in cases of limited dosage strengths and dosage forms, drug allergies to certain ingredients, pediatrics, chemotherapy, and veterinary medicine. Further, compounded medicines enhance pharmacist contribution to developing and implementing patient therapeutic plans and provide customized medications of high pharmaceutical quality.

Get Sample PDF of at @ https://www.theinsightpartners.com/sample/TIPRE00005407/

Compounding Pharmacies Market Competition Landscape and Key Developments:

Fagron, Inc.
Elixir Compounding Pharmacy
Avella specialty pharmacy
B. Braun Melsungen AG
PharMEDium Healthcare Holdings, Inc.
Fresenius Kabi AG
Belle Santé Diagnostic & Therapeutic Institute Pvt. Ltd
Triangle Compounding Pharmacy
Vertisis Custom Pharmacy
US Compounding Inc

Compounding Pharmacies Market – by Product

Oral Medications
Topical Medications
Suppositories
Others

Compounding Pharmacies Market – by Therapeutic Area

Pain Medications
Hormone Replacement Therapies (HRT)
Dermatological Applications
Others

The US is encountering a rapid drug shortage, which has caused difficulties for health care facilities, clinicians, patients, and federal regulators. Challenges in manufacturing, acquisition of raw materials, regulatory issues, and business arrangements, as well as disruptions in the supply chain are the major factors causing drug shortage. According to the American Society of Health-System Pharmacists, drug shortages can negatively affect drug therapy and cause delay in medical procedures resulting in medication errors. Drug shortages range from simple medicines, such as buffered aspirin, to life-saving medications—such as cancer antibiotics and cancer chemotherapy agents—and emergency medications, such as epinephrine.

Report Highlights:

• Comprehensive overview of parent market & substitute market
• Changing market dynamics in the industry (COVID & Economic Impact Analysis)
• In-depth market segmentation (Trends, Growth with Historical & Forecast Analysis)
• Recent industry trends and development activity
• Competitive landscape (Heat Map Analysis for Emerging Players & Market Share Analysis for Major Players along with detailed Profiles)

Buy this Report Research @ https://www.theinsightpartners.com/buy/TIPRE00005407/

About Us:

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Healthcare, Manufacturing, Automotive and Defense.

Contact Us:

Call: +1-646-491-9876
Email: sales@theinsightpartners.com

Prashant Tambe
Prashant Tambe
An expert in SEO, Prashant carries an experience of over five years in the industry. He has the ability to analyze global industry trends that helps the leaders to make smarter decisions. An electrical, electronics and communication engineer, Prashant is able to predict future trends as they are changing fast with technological development.